AMSTERDAM, September 19, 2017 /PRNewswire/ --
Elsevier, the information analytics business specializing in science and health, and the Board of Executive Editors of Elsevier's Tetrahedron journal series today announced that the 2017 Tetrahedron Prize for Creativity in Organic Chemistry has been awarded to Professor Laura L. Kiessling of the Massachusetts Institute of Technology. She receives the award for her outstanding contributions to organic chemistry.
Professor Stephen Martin, Chairman of the Editorial Board of Tetrahedron Journals, said on announcing this year's winner, "Professor Kiessling has performed truly ground-breaking research in the broad field of chemical glycobiology, an important field she has played a major role in shaping. Using creative chemical strategies to interrogate and elucidate cellular pathways involving glycans is a hallmark of her work. Her creative contributions to diverse areas ranging from exploring glycan synthesis in mycobacteria to probing mechanisms of differentiation in human stem cells have had a profound influence in chemical biology."
"Hearing about the Tetrahedron Prize was both surprising and special. The previous winners are a list of those who have inspired me, including my mentors Stuart Schreiber and Peter Dervan," Professor Kiessling commented. "This honor is also important to me as it recognizes a change in the diversity of researchers in organic and bioorganic chemistry, and diversifying our field is critical for its vitality."
The Tetrahedron Prize was established in 1980 and is intended to honor the memory of the founding co-Chairmen of the Tetrahedron publications, Professor Sir Robert Robinson and Professor Robert Burns Woodward. It is awarded annually and consists of a gold medal, a certificate, and a monetary amount of $15,000, which will be presented during the 2018 Fall National Meeting of the American Chemical Society in Boston, Massachusetts, USA (August 19-23, 2018).
Elsevier is a global information analytics business that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com.